Lakestar is leading the Series B round; Elaia and several existing investors are also participating. The funding comes two years after Doccla raised a $17 million Series A.
Doccla, which competes with companies like Graphnet and Huma among others, will use the funding in part to hire local teams in new markets. And while the startup’s main focus up to now has been to contract with health services — they include local NHS Trusts in the U.K and Ireland’s Health Service Executive (HSE) — for “virtual bed” tech for patients, it is also supporting virtual clinical trials for pharmaceutics companies; and it has its eye on building a data insights business around all of it.